Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarach
RecruitingNCT05103566Phase: NAStarted 2022-10-04
Summary
This is a single-site, single-arm, open-label pilot study assessing the safety, feasibility, and efficacy of non-invasive vagus nerve stimulation (nVNS), gammaCore, for the acute treatment of aneurysm
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
85 Years
Locations
Massachusetts General HospitalBoston, Massachusetts, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05103566